Expression and prognostic significance of miR-375 and miR-221 in liver cancer

Dafei Xie,Peiwen Yuan,Dong Wang,Hua Jin,Hui Chen
DOI: https://doi.org/10.3892/ol.2017.6423
2017-06-20
Oncology Letters
Abstract:The purpose of this study was to investigate the expression of <i>miR-375</i> and <i>miR-221</i> in liver cancer, and examine the correlations with pathological parameters and prognosis. We collected tumors and tumor-adjacent normal tissue from 70 patients with liver cancer admitted to the Department of General Surgery of Zhejiang Hospital. The expression of <i>miR-375</i> by RT-qPCR was significantly lower in liver cancer tissues than that in the tumor-adjacent normal tissues, and the low expression was correlated with the lymphatic metastasis and TNM stage. By contrast, the expression of <i>miR-221</i> was significantly higher in liver cancer than that in the tumor-adjacent tissues, and the high expression was correlated with the lymphatic metastasis and TNM stage. The overall 5-year survival rate of patients was 12.9% (9/70). Single-factor survival analysis revealed that <i>miR-375</i> and <i>miR-221</i> were the factors affecting the overall survival rate of liver cancer (P&lt;0.05) and multivariate survival analysis by Cox proportional hazards model showed that <i>miR-375</i> and <i>miR-221</i> were the independent factors affecting the survival time of patients with liver cancer. Low expression of <i>miR-375</i> and high expression of <i>miR-221</i> are closely correlated with the occurrence and development of liver cancer, especially lymphatic metastasis and TNM stage. Thus, <i>miR-375</i> and <i>miR-221</i> can serve as reference biomarkers for guiding the treatment of liver cancer and for estimating prognosis.
oncology
What problem does this paper attempt to address?